operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with AURA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then AURA could also see price increases.
Ticker / NAME | Correlation To PBYI | 1D Price Change % | ||
---|---|---|---|---|
PBYI | 100% | +0.67% | ||
AURA - PBYI | 33% Loosely correlated | -3.48% | ||
SLRN - PBYI | 33% Poorly correlated | -13.71% | ||
VIR - PBYI | 32% Poorly correlated | -3.79% | ||
FHTX - PBYI | 32% Poorly correlated | -0.56% | ||
ABCL - PBYI | 31% Poorly correlated | -5.48% | ||
More |
Ticker / NAME | Correlation To PBYI | 1D Price Change % |
---|---|---|
PBYI | 100% | +0.67% |
cancer theme (82 stocks) | 28% Poorly correlated | -2.35% |
treatment theme (56 stocks) | 27% Poorly correlated | -1.02% |
drugs theme (254 stocks) | 24% Poorly correlated | -1.67% |
biopharmaceuticals theme (50 stocks) | 21% Poorly correlated | -2.60% |
biotechnology theme (238 stocks) | 17% Poorly correlated | -1.76% |